Reduction of insulin dose on changing diabetic children from standard to monocomponent insulins

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Diabetes Management

Background:

• Children with diabetes often require high insulin doses.
• Standard insulin preparations can lead to dose escalation over time.
• Monocomponent insulins offer potential benefits in diabetes management.

Purpose of the Study:

• To evaluate the effect of switching to monocomponent insulin on insulin dosage in children with diabetes.
• To assess the impact of monocomponent insulin on overall diabetic control.

Main Methods:

• A cohort of 21 pediatric patients with diabetes requiring >50 units of standard insulin daily was studied.
• Patients were switched from standard insulin to monocomponent insulin.
• Insulin dosage, clinical control, home urine tests, and 24-hour urine glucose excretion were monitored before and after the switch.

Main Results:

• A significant decrease in daily insulin requirement was observed, from a mean of 77 units before the switch to 53 units after.
• The switch to monocomponent insulin was associated with a general improvement in diabetic control.
• Improvements were supported by clinical assessments and objective measures like home urine tests and 24-hour urine glucose excretion.

Conclusions:

• Monocomponent insulin therapy can effectively reduce insulin dosage requirements in pediatric patients with diabetes.
• This reduction in insulin dose is linked to improved glycemic control in children.
• Monocomponent insulin represents a viable therapeutic option for managing insulin requirements in diabetic children.